| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e4561a3d5c70285227be39a902a71c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cb2442ad4b6250ba4dfe34cde7a68e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_863faaa576ab3a8464070e69bf3b2a05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56f430bfb8f53263f4a79c6a3b393805
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_64e05ffb40440eaf88d5700dfc20f278 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-811
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1019 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23G4-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 |
| filingDate |
1998-04-27^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e0d91c2c99b40ec46f6bbef971ca0a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f27066671e16bd93f4e661d4674e2188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ade18914b6f57f97080a9553a474ac3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c359dec9a4a16683d03bc5f7f8cf6602 |
| publicationDate |
1998-11-05^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9849197-A1 |
| titleOfInvention |
Oligopeptidic inhibitors of elastases and methods of preparation thereof |
| abstract |
The invention relates to oligopeptidic inhibitors of elastases, with potent inhibition of leukocyte elastase. The inhibitors are isobutylamides of tetra- to pentapeptides which have substituted lysine incorporated in the N-terminal portion of the molecule. This dibasic aminoacid is alternatively substituted at both α- and ε-aminogroups with higher saturated acids or with φ-carboxylalkanoylic residues. In one type of these compounds the ε-aminogroup is acylated with an acyl-alanine, where an acyl means a higher saturated acid. The compounds of this invention are the active components of medicinal preparations used mainly in dental practice. |
| priorityDate |
1997-04-30^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |